22.22% rise: 1ST.AX 1st Group Limited ASX pre-market 24 Jan 2026: watch volume
We note 1ST.AX stock is trading higher in pre-market on 24 Jan 2026 after a 22.22% intraday jump to A$0.011 on volume of 2,075,140 shares. The move outpaces Healthcare sector gains and lifts market cap to about A$15,586,889.00. We link the rally to small-cap momentum and broader risk-on flows after recent trade headlines. Meyka AI’s models and grade are included below to frame the rally and near-term outlook for investors on the ASX in AUD.
1ST.AX stock: price move and drivers
The stock opened at A$0.011 and shows a +0.002 change from the prior close of A$0.009. Volume at 2,075,140 is 3.06x the average of 678,621, signalling headline-driven or speculative buying. Sector context matters: Healthcare recorded a +2.42% one-day move, helping small-cap healthcare names. Macro relief on tariffs and positive small-cap sentiment likely lifted 1st Group Limited (1ST.AX) in this pre-market session. See market updates from CNBC and Reuters markets for the broader market drivers.
Financials and valuation for 1ST.AX analysis
Key metrics: EPS -0.01, PE -1.10, price avg 50 A$0.00917, price avg 200 A$0.00796, shares outstanding 1,416,989,952. Price to sales ratio is 3.49, EV/Sales 4.52, and current ratio 0.83. The company operates health marketplaces and SaaS telehealth solutions in Australia. Revenue per share TTM is A$0.00340 and net income per share TTM is -A$0.00279, underscoring negative profitability despite growth in some operating metrics.
Technicals, volume and liquidity for 1ST.AX stock
Technically, immediate resistance sits near the year high A$0.015, with support around A$0.004 (year low). The 50-day average at A$0.00917 suggests the current price is above short-term trend. The high relative volume (relVolume 3.06) improves tradability but also increases short-term volatility. With 1,416,989,952 shares outstanding, liquidity can swing quickly; bid-ask spreads tend to widen on microcaps like 1ST.AX.
Meyka AI rates 1ST.AX with a score out of 100
Meyka AI rates 1ST.AX with a score of 61.35 out of 100 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The model flags improved short-term momentum but persistent negative earnings and tight liquidity as restraints. These grades are not guarantees and are for informational purposes only.
Meyka AI’s forecast and price targets for 1ST.AX forecast
Meyka AI’s forecast model projects A$0.00718 in 12 months. That projection compared to the current A$0.011 implies an implied downside of -34.75%. Near-term technical levels: resistance A$0.015 (+36.36%) and a bullish scenario target A$0.020 (+81.82%) if revenue traction and margin improvement follow. Forecasts are model-based projections and not guarantees.
Risks, catalysts and trading strategy
Key risks: ongoing negative EPS, thin liquidity, extended payables and tight current ratio. Catalysts include improved GoBookings or MyHealth1st adoption, contract wins in corporate/government SaaS, or positive sector M&A. For traders we recommend short-term position sizing, watching volume and stop-loss levels; for longer-term investors, verify revenue growth and cash-flow improvement before adding to a portfolio.
Final Thoughts
1ST.AX stock moved sharply in pre-market trade on 24 Jan 2026, up 22.22% to A$0.011 on unusually heavy volume of 2,075,140 shares. The rise appears driven by small-cap momentum and broader trade-related market relief. Our Meyka AI grade of 61.35 (B/HOLD) balances the stock’s rally against weak profitability (EPS -0.01) and limited liquidity. Meyka AI’s model projects A$0.00718 in 12 months, implying -34.75% from today; traders should treat that as a cautionary base case. Short-term traders can target A$0.015 as the next resistance and consider A$0.020 as an upside scenario only if material revenue improvement appears. All forecasts are model-based projections and not guarantees. For more detailed, real-time data see our Meyka stock page for 1ST.AX and monitor sector flows and company updates before acting.
FAQs
Why did 1ST.AX stock spike pre-market today?
1ST.AX stock rose on 24 Jan 2026 due to heavy buying and small-cap strength after trade-related market relief. Volume was 2,075,140, about 3.06x average, suggesting speculative or news-driven flows rather than confirmed company-specific fundamentals.
What is Meyka AI’s current view on 1ST.AX stock?
Meyka AI gives 1ST.AX a score of 61.35/100 (Grade B, HOLD). The grade balances recent momentum with negative earnings, thin liquidity and mixed valuation metrics. This is informational, not investment advice.
What price targets and forecast exist for 1ST.AX?
Near-term technical resistance is A$0.015 (+36.36%). A bullish scenario reaches A$0.020 (+81.82%). Meyka AI’s 12-month forecast is A$0.00718, implying -34.75% from the current A$0.011. Forecasts are not guarantees.
What are the main risks for 1ST.AX investors?
Primary risks include negative EPS (-0.01), low current ratio (0.83), extended payables and limited free cash flow. Thin market liquidity can amplify price moves and widen spreads, increasing execution risk for larger positions.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
